Browse > Article
http://dx.doi.org/10.3340/jkns.2020.0303

The Protective Effects of Statins towards Vessel Wall Injury Caused by a Stent Retrieving Mechanical Thrombectomy Device : A Histological Analysis of the Rabbit Carotid Artery Model  

Lee, Seung Hwan (Department of Neurosurgery, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University)
Shin, Hee Sup (Department of Neurosurgery, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University)
Oh, Inho (Department of Neurosurgery, Veterans Health Service Medical Center)
Publication Information
Journal of Korean Neurosurgical Society / v.64, no.5, 2021 , pp. 693-704 More about this Journal
Abstract
Objective : Endovascular mechanical thrombectomy (MT) has been regarded as one of the standard treatments for acute ischemic stroke caused by large vessel occlusion. Despite the wide use of stent retrievers for MT, arterial intimal damage caused when deployed stent is pulled has been a certain disadvantage. We hypothesized that statin could protect and stabilize vessel damage after endovascular MT using a stent retriever. In this animal study, we observed the protective effects of the statins towards MT-induced vessel wall injury. Methods : Twenty-eight carotid arteries of fourteen rabbits were used in the experiments with MT using stent retriever. We divided the rabbits into four groups as follows : group 1, negative control; group 2, positive control; group 3, statin before MT; and group 4, statin after MT. After MT procedures, we harvested the carotid arteries and performed histomorphological and immunohistochemical analyses. Results : In histomorphological analysis with hematoxylin and eosin and Masson's trichrome stain, significant intimal thickening (p<0.05) was observed in the positive control (group 2), compared to in the negative control (group 1). Intimal thickening was improved in the statin-administered groups (groups 3 and 4 vs. group 2, p<0.05). We also observed that statin administration after MT (group 4) resulted in a more effective decrease in intimal thickness than statin administration before MT (group 3) (p<0.05). We performed immunohistochemical analysis with the antibodies for tumor necrosis factor-alpha (TNF-α), cluster of differentiation (CD)11b, and CD163. In contrast to the negative control (group 1), the stained percentage areas of all immunological markers were markedly increased in the positive control (group 2) (p<0.05). Based on statin administration, the percentage area of TNF-α staining was significantly reduced (p<0.05) in group 3, compared to the positive control group (group 2). However, significant differences were not observed for CD11b and CD163 staining. In group 4, no significant differences were observed for TNF-α, CD11b, and CD163 staining (p≥0.05). The differences in the percentage areas of the different markers between the statin-administered groups (groups 3 and 4) were also not revealed. Conclusion : We presented that statin administration before and after MT exerted protective effects towards vessel wall injury. The efficacy of statins was greater post-administration than pre-administration. Thus, statin administration in routine prescriptions in the peri-procedural period is strongly advised.
Keywords
Thrombectomy; Stents; Hydroxymethylglutaryl-CoA reductase inhibitors; Rabbits;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. : Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372 : 2285-2295, 2015   DOI
2 Sirtori CR : The pharmacology of statins. Pharmacol Res 88 : 3-11, 2014   DOI
3 Laufs U, Liao JK : Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273 : 24266-24271, 1998   DOI
4 Laufs U, Marra D, Node K, Liao JK : 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J Biol Chem 274 : 21926-21931, 1999   DOI
5 Liao JK, Laufs U : Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45 : 89-118, 2005   DOI
6 McTaggart F : Comparative pharmacology of rosuvastatin. Atheroscler Suppl 4 : 9-14, 2003   DOI
7 Yin NS, Benavides S, Starkman S, Liebeskind DS, Saver JA, Salamon N, et al. : Autopsy findings after intracranial thrombectomy for acute ischemic stroke: a clinicopathologic study of 5 patients. Stroke 41 : 938-947, 2010   DOI
8 Smith WS : Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 27 : 1177-1182, 2006
9 Sterpetti AV, Cucina A, Lepidi S, Randone B, Stipa F, Aromatario C, et al. : Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production. J Vasc Surg 23 : 568-575, 1996   DOI
10 Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. : 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 129 : S1-S45, 2014   DOI
11 Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. : Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372 : 1009-1018, 2015   DOI
12 Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. : A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372 : 11-20, 2015   DOI
13 Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. : Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 41 : 2254-2258, 2010   DOI
14 Brekenfeld C, Schroth G, El-Koussy M, Nedeltchev K, Reinert M, Slotboom J, et al. : Mechanical thromboembolectomy for acute ischemic stroke: comparison of the catch thrombectomy device and the Merci Retriever in vivo. Stroke 39 : 1213-1219, 2008   DOI
15 Chen Z, Fukutomi T, Zago AC, Ehlers R, Detmers PA, Wright SD, et al. : Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids. Circulation 106 : 20-23, 2002   DOI
16 Faul F, Erdfelder E, Buchner A, Lang AG : Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41 : 1149-1160, 2009   DOI
17 del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, et al. : Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32 : 78-86, 1992   DOI
18 Faul F, Erdfelder E, Lang AG, Buchner A : G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39 : 175-191, 2007   DOI
19 Gascou G, Lobotesis K, Machi P, Maldonado I, Vendrell JF, Riquelme C, et al. : Stent retrievers in acute ischemic stroke: complications and failures during the perioperative period. AJNR Am J Neuroradiol 35 : 734-740, 2014   DOI
20 Bradley JR : TNF-mediated inflammatory disease. J Pathol 214 : 149-160, 2008   DOI
21 Gauthier TW, Scalia R, Murohara T, Guo JP, Lefer AM : Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol 15 : 1652-1659, 1995   DOI
22 Laufs U, La Fata V, Plutzky J, Liao JK : Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 : 1129-1135, 1998   DOI
23 Lee SG, Lee SJ, Thuy NVP, Kim JS, Lee JJ, Lee OH, et al. : Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis. PLoS One 14 : e0215604, 2019   DOI
24 Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. : Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50 : e344-e418, 2019
25 Neville RF, Sidawy AN : Myointimal hyperplasia: basic science and clinical considerations. Semin Vasc Surg 11 : 142-148, 1998
26 Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. : Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351 : 2170-2178, 2004   DOI
27 Arai D, Ishii A, Chihara H, Ikeda H, Miyamoto S : Histological examination of vascular damage caused by stent retriever thrombectomy devices. J Neurointerv Surg 8 : 992-995, 2016   DOI
28 Auerbach BJ, Krause BR, Bisgaier CL, Newton RS : Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin. Atherosclerosis 115 : 173-180, 1995   DOI
29 Mordasini P, Hiller M, Brekenfeld C, Schroth G, Fischer U, Slotboom J, et al. : In vivo evaluation of the Phenox CRC mechanical thrombectomy device in a swine model of acute vessel occlusion. AJNR Am J Neuroradiol 31 : 972-978, 2010   DOI
30 Mordasini P, Frabetti N, Gralla J, Schroth G, Fischer U, Arnold M, et al. : In vivo evaluation of the first dedicated combined flow-restoration and mechanical thrombectomy device in a swine model of acute vessel occlusion. AJNR Am J Neuroradiol 32 : 294-300, 2011   DOI
31 Pecoraro V, Moja L, Dall'Olmo L, Cappellini G, Garattini S : Most appropriate animal models to study the efficacy of statins: a systematic review. Eur J Clin Invest 44 : 848-871, 2014   DOI
32 Perren F, Kargiotis O, Pignat JM, Pereira VM : Hemodynamic changes may indicate vessel wall injury after stent retrieval thrombectomy for acute stroke. J Neuroimaging 28 : 412-415, 2018   DOI
33 Ribo M, Alvarez-Sabin J, Montaner J, Romero F, Delgado P, Rubiera M, et al. : Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 37 : 1000-1004, 2006   DOI
34 Kato M, Sada T, Mizuno M, Kitayama K, Inaba T, Koike H : Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits. J Cardiovasc Pharmacol 46 : 556-562, 2005   DOI
35 Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. : Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372 : 1019-1030, 2015   DOI
36 Haussen DC, Rebello LC, Nogueira RG : Optimizating clot retrieval in acute stroke: the push and fluff technique for closed-cell stentrievers. Stroke 46 : 2838-2842, 2015   DOI
37 Kurre W, Perez MA, Horvath D, Schmid E, Bazner H, Henkes H : Does mechanical thrombectomy in acute embolic stroke have long-term side effects on intracranial vessels? An angiographic follow-up study. Cardiovasc Intervent Radiol 36 : 629-636, 2013   DOI
38 Istvan ES, Deisenhofer J : Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292 : 1160-1164, 2001   DOI
39 Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. : Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372 : 2296-2306, 2015   DOI